Vise Technologies, Inc. Amgen Inc Transaction History

Vise Technologies, Inc.

$771 Million
Q3 2024

A detailed history of Vise Technologies, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Vise Technologies, Inc. holds 4,176 shares of AMGN stock, worth $1.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

4,176

Previous 3,870 7.91%

Holding current value

$1.1 Million

Previous $1.21 Million 11.25%

% of portfolio

0.17%

Previous 0.21%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $94,670 - $103,238	306 Added 7.91%	4,176 $1.35 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $103,523 - $125,808	-394 Reduced 9.24%	3,870 $1.21 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $391,743 - $472,883	-1,457 Reduced 25.47%	4,264 $1.21 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $283,059 - $319,325	-1,107 Reduced 16.21%	5,721 $1.65 Million
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $223,241 - $277,160	1,021 Added 17.58%	6,828 $1.84 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $197,985 - $234,113	924 Added 18.92%	5,807 $1.29 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $171,826 - $209,427	-761 Reduced 13.48%	4,883 $1.18 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $452,334 - $574,744	1,975 Added 53.83%	5,644 $1.48 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $10,774 - $12,151	48 Added 1.33%	3,669 $827,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $692 - $770	-3 Reduced 0.08%	3,621 $881,000
Q1 2022 Jun 08, 2022	BUY	$219.27 - $242.57 $239,223 - $264,643	1,091 Added 43.07%	3,624 $876,000
Q4 2021 Jun 07, 2022	BUY	$198.88 - $227.6 $503,763 - $576,510	2,533 New	2,533 $570,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.

Account

Vise Technologies, Inc. Amgen Inc Transaction History